Logo Université de Strasbourg


Sur ce site

Sur le Web du CNRS

Accueil > News > Investment for the Future: the LabEx project MEDALIS selected

Investment for the Future: the LabEx project MEDALIS selected

Research teams from UMR 7242 - Biotechnology and cell signaling at Irebs are partners of the project MEDALIS that was selected after applying to a french governmental call for projects entitled "Laboratories of Excellence" (LabEx).

Prime Minister Francois Fillon presented Friday, March 25, 2011 at the Hotel Matignon with Valérie Pécresse, Minister of Higher Education and Research, the 100 winners of the call for projects "Laboratoires d’Excellence".

With a total of one billion euros, this call for proposals aimed at assigning substantial grants to laboratories with significant international visibility allowing them to compete with their foreign counterparts, attracting researchers and lecturers of international renown, and building an integrated policy for high level research, training and development.

The teams of V. Schreiber and F. Dantzer (Poly(ADP-ribosyl)ation and genome integrity), J.-L. Galzi and F. Simonin (Dynamics of GPRCs) et (GPRCs and pain r), and C. Nebigil-Désaubry (GPCRs and cardiobiology) are partners with other research teams in Strasbourg involved in MEDALIS, a project for a new Drug Research Center.

The purpose of this project is the establishment of a research center for drugs in the field of cancer and inflammation. The project will develop innovative approaches:

  • to target, as part of an anti-cancer strategy, new members of the poly (ADP-ribose) polymerases (PARPs), proteins involved in various cellular processes leading to the programmed cell death;
  • to fight cancer types and inflammation by targeting supramolecular complexes;
  • to develop the use of microfluidic technology for high throughput screening.

Research should allow innovative development of more efficient, accurate drugs having fewer side effects to treat cancer patients.